Our Vision
We aim to find innovative therapeutic approaches and diagnostic methods to better overcome challenges encountered in clinical practice. These approaches will be based on thorough and comprehensive investigation of biologic and molecular processes in head and neck cancer
Our Team
- Dr. Nidal Muhanna, Lab PI, Department of Otolaryngology Head & Neck Surgery and Maxillofacial Surgery;General Medicine; Sackler Faculty of Medicine
- Dr. Dor Rafael, Lab manager
- Dr. Galya Lerman
- Bar Kamhin
- Dr. Razan Masarwr- Phd student
- Haya Kravitz- PhD student
- Dr. Alexandra Dorman
- Dr .Liyona Kampel Furman
- Dr. Narin Carmel
- Dr. Yotam Lior
Research
targeting and siRNA-based gene silencing
This is done via exosomes and lipid-based nanpoparticles (LNPs) as endogenous and synthetic (respectively) delivery systems.
(exosomes or LNPs) targeting
toward cancer cells for therapeutic, diagnostics and other applications.
more specifically CAF’s, in order to examine the relationship between cancer cells and fibroblasts, for the prevention of key steps in cancer growth.
(EV’s) of human embryonic stem cells (hESC), in hope to harness them as a therapeutic delivery tool.
The lab is using cutting edge molecular tools and technologies to examine the genetic signature of recurrent disease.
to detect cancer circDNA
Designing novel molecular tools to detect cancer circDNA in blood samples and saliva (“liquid biopsy”) before any physical signs appears. These tools will also be used to monitor cancer recurrence or metastases
.
Highlight Publications